Once you receive your genetic results, you cannot un-know that information. The terms warn that findings may be unwelcome, including unexpected health risks or surprising ancestry revelations, and that future research advances may add new meaning to your existing data.
This analysis describes what 23andMe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
Genetic information is uniquely personal and permanent. This clause is an important consumer warning that psychological, familial, and medical consequences of obtaining genetic results cannot be reversed, and users should consider this carefully before testing.
The updated Terms now apply only to users who live outside the United States, Canada, EEA, UK, and Switzerland, or who access the Services from outside those regions. US, Canadian, EEA, UK, and Swiss…
The updated Terms of Service now apply exclusively to users in the United States, narrowing the geographic scope from the prior version that addressed users in multiple regions. The terms now contain…
The updated terms now apply only to users who live outside or access services outside the United States, Canada, EEA, UK, and Switzerland. Previously, the terms applied to US-based users. The terms a…
Receiving your 23andMe results is a one-way decision: you cannot un-know information about your ancestry, health predispositions, or family relationships. The terms explicitly acknowledge that findings may be distressing, including discovering that a family member is not a genetic relative or learning of an elevated risk for a medical condition.
Cross-platform context
See how other platforms handle Irrevocability of Genetic Knowledge Disclosure and similar clauses.
Compare across platforms →Monitoring
23andMe has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 10 platforms.
"Once you obtain your Genetic Information, the knowledge is irrevocable. You should not assume that any information provided to you, whether now or as genetic research advances, will be welcome or positive. As research advances, you may need to obtain further Services from 23andMe, your physician, a genetic counselor, or other healthcare provider.— Excerpt from 23andMe's 23andMe Terms of Service
(1) REGULATORY LANDSCAPE: This disclosure engages informed consent principles relevant to genetic testing in multiple jurisdictions. In some countries, regulatory bodies require specific informed consent processes for genetic testing that discloses health-related information. The terms' statement that services are for informational and educational use only does not necessarily exempt 23andMe from jurisdiction-specific genetic testing disclosure requirements. Consumer protection authorities in served markets may evaluate whether this disclosure constitutes adequate informed consent under national law. (2) GOVERNANCE EXPOSURE: Medium. The irrevocability warning is a proactive disclosure that partially satisfies informed consent norms, but its placement in a Terms of Service document rather than a dedicated pre-test informed consent form may be insufficient under some national regulatory frameworks. The mention of potential psychological distress without a mandatory referral mechanism may attract scrutiny in jurisdictions with specific genetic counseling requirements. (3) JURISDICTION FLAGS: Australia, New Zealand, and several other served jurisdictions have specific frameworks around genetic testing consent and disclosure. In some markets, the adequacy of a terms-of-service disclosure as a substitute for a formal informed consent process for health-related genetic information is legally uncertain. (4) CONTRACT AND VENDOR IMPLICATIONS: This provision does not create direct vendor or B2B contract implications, but it signals the sensitivity of the service context that downstream partners handling genetic data should account for in their own compliance frameworks. (5) COMPLIANCE CONSIDERATIONS: Compliance teams should assess whether the irrevocability disclosure, combined with the recommendation to consult a genetic counselor, meets the informed consent standards required in each jurisdiction where the international service is offered. The terms recommend but do not require consultation with a genetic counselor prior to testing, which may be insufficient in jurisdictions that mandate pre-test counseling for health-related genetic services.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 1 platform + weekly digest. Watcher: 10 platforms + same-day alerts. No credit card required.
Professional Governance Intelligence
Need to monitor specific governance provisions?
Professional includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
Genetic information is uniquely personal and permanent. This clause is an important consumer warning that psychological, familial, and medical consequences of obtaining genetic results cannot be reversed, and users should consider this carefully before testing.
Receiving your 23andMe results is a one-way decision: you cannot un-know information about your ancestry, health predispositions, or family relationships. The terms explicitly acknowledge that findings may be distressing, including discovering that a family member is not a genetic relative or learning of an elevated risk for a medical condition.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by 23andMe.